What The Pause In The Johnson & Johnson And Eli Lilly Covid Drug Trials May Mean

Rushing toward approval of Covid vaccines and treatments—while understandable—can be dangerous.

Read the full post on Forbes - Healthcare

William A. Haseltine, Contributor